Search results
TikToker Kimberley Nix Dead at 31 from Metastatic Sarcoma, Leaves Final Video for Followers: 'I've...
People via Yahoo News· 7 days agoAccording to the National Cancer Institute, undifferentiated pleomorphic sarcoma typically forms in...
TikToker who documented journey with metastatic sarcoma dies at 31, released final video saying...
NBC NEWS· 6 days agoAs a final farewell, Nix published a last video on her TikTok page to her 148,000 followers saying,...
Moleculin begins NIH-funded Phase II glioblastoma treatment trial
Clinical Trials Arena via Yahoo Finance· 5 hours agoApart from NIH, BrainUp, a non-profit organisation focusing on creating awareness on brain cancer,...
TikToker Kimberly Nix dies aged 31
The Independent US via AOL· 7 days agothe caption read. “If you wish, please donate through my link in bio to sarcoma cancer research and follow my husband in his updates.” According to the...
Dr. Kimberley Nix Dies: Popular Social Media Personality Shared Her Cancer Journey, Was 31
Deadline via Yahoo News· 7 days agoDr. Kimberley Nix, who chronicled her three-year battle with metastatic sarcoma on TikTok and...
Beloved TikToker announces her own death in her final ‘Get Ready With Me’ video
Miami Herald via Yahoo News· 6 days ago“Symptoms of sarcoma are so important because there is no screening test,” Nix explained in her...
TikTok Star Kimberley Nix Dead at 31, Leaves Touching Final Video Behind
popculture.com· 6 days agoNix passed away on Wednesday, May 8 at the age of 31, announcing her passing in a final video...
Solving the Cancer Mystery That Devastated My Family
The Wall Street Journal· 6 days agoWhen it was published by the Annals of Internal Medicine in October 1969, the title reflected their hesitation: “Soft-Tissue Sarcomas ...
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoOur clinical development strategy is designed to create the opportunity for enva to broadly benefit patients with sarcoma in the frontline, adjuvant and neoadjuvant settings ...
Telix Pharmaceuticals (OTCMKTS:TLPPF) Shares Up 0.8%
ETF DAILY NEWS· 6 days ago...CDx for the diagnosis and treatment of glioblastoma (brain cancer); TLX66-CDx to treat bone marrow conditioning and rare diseases; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; TLX250, which is in Phase II clinical trials for the diagnosis and treatment of kidney cancer;...
